(Q36506102)

14 August 2017

1 reference

title

Computed tomographic evaluation of patients with tardive dyskinesia (English)

1 reference

14 August 2017

1 reference

W. F. Hoffman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1677262

26 October 2022

D. E. Casey

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1677262

26 October 2022

language of work or name

English

0 references

publication date

1 July 1991

1 reference

full work available at URL

14 August 2017

https://api.elsevier.com/content/article/PII:092099649190048V?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90048-V

https://api.elsevier.com/content/article/PII:092099649190048V?httpAccept=text/plain

26 October 2022

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90048-V

26 October 2022

published in

Schizophrenia Research

1 reference

14 August 2017

volume

5

1 reference

14 August 2017

issue

1

1 reference

14 August 2017

page(s)

1-12

1 reference

Tardive dyskinesia: relation to computer-tomographic, endocrine, and psychopathological variables.

14 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90048-V

Relationship of the Actions of Neuroleptic Drugs to the Pathophysiology of Tardive Dyskinesia

26 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90048-V

Computerized tomography in tardive dyskinesia. Evidence of structural abnormalities in the basal ganglia system

26 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90048-V

Nuclear magnetic resonance brain imaging in chronic schizophrenia

26 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90048-V

Striatal dopamine D2 receptors in tardive dyskinesia: PET study

26 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90048-V

Tardive dyskinesia: clinical correlation with computed tomography in patients aged less than 60 years

26 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90048-V

Effects of neuroleptic adjustment on clinical condition and tardive dyskinesia in schizophrenic patients

26 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90048-V

Huntington's dementia. Clinical and neuropsychological features

26 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90048-V

Pharmacological characterization of tardive dyskinesia

26 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90048-V

26 October 2022

Q64895699

13

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90048-V

Tardive Dyskinesia and Dementia

26 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90048-V

Diagnostic Criteria for Use in Psychiatric Research

26 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90048-V

Withdrawal syndromes associated with antipsychotic drugs

26 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90048-V

Computerized tomography in patients with tardive dyskinesia

26 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90048-V

Tardive dystonia and severe tardive dyskinesia. A comparison of risk factors and prognosis

26 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90048-V

Tardive dyskinesia. A discontinuation study.

26 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90048-V

MRI scans in patients with tardive dyskinesia

26 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90048-V

Neuroleptic-induced parkinsonism in older schizophrenics

26 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90048-V

Semiautomated Methods for Quantitating CSF Volume on Cranial Computed Tomography

26 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90048-V

Therapeutic strategies against tardive dyskinesia. Two decades of experience

26 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90048-V

Evaluation of CT scans in tardive dyskinesia

26 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90048-V

Emergency management of the starving psychiatric patient

26 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90048-V

Tardive dyskinesia: prevalence and risk factors, 1959 to 1979.

26 October 2022

31

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90048-V

Noradrenergic and neuroradiological abnormalities in tardive dyskinesia.

26 October 2022

32

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90048-V

Treatment of tardive dyskinesia. II. Short-term efficacy of dopamine-blocking agents haloperidol and thiopropazate.

26 October 2022

33

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90048-V

Sub-syndromes of tardive dyskinesia.

26 October 2022

34

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90048-V

Serum and CSF antibody titres to seven common viruses in schizophrenic patients.

26 October 2022

35

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90048-V

Tardive dyskinesia in schizophrenics under 60 years of age.

26 October 2022

37

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90048-V

Lateral ventricular size and drug-induced Parkinsonism

26 October 2022

39

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90048-V

Regional, reversible ultrastructural changes in rat brain with chronic neuroleptic treatment

26 October 2022

40

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90048-V

Computer-interactive method for quantifying cerebrospinal fluid and tissue in brain CT scans: effects of aging.

26 October 2022

47

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90048-V

Research Diagnoses for Tardive Dyskinesia

26 October 2022

48

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90048-V

A rating scale for tardive dyskinesia

26 October 2022

50

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90048-V

Memory impairment in schizophrenic patients with tardive dyskinesia.

26 October 2022

51

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90048-V

CT abnormalities in tardive dyskinesia

26 October 2022

52

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90048-V

The ventricular-brain ratio using planimetric measurement of EMI scans

26 October 2022

53

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90048-V

Schizophrenia with good and poor outcome. II: Cerebral ventricular size and its clinical significance

26 October 2022

55

1 reference

https://api.crossref.org/works/10.1016/0920-9964(91)90048-V

26 October 2022

Identifiers

1 reference

14 August 2017

1 reference